The European Medicines Agency has approved the dissolvable version of Levitra that we wrote about some months ago. Bayer, the manufacturers, state that because the treatment dissolves on the tongue and therefore is assimilated into the bloodstream at a faster rate than swallowing the tablet, those taking Levitra will have more control over their sex life.
The dissolvable formulation will be launched in Europe in November of this year. It has already been approved by the FDA in the US.
822 men who had experienced erectile dysfunction for over 6 months took part in two studies and the orodispersable Levitra came out on top showing itself to be far superior to the placebo and as effective as the hard tablet form. Instead of taking the hard tablet form one hour before sexual intercourse, the dissolvable form will give men the freedom to be more spontaneous although Bayer has not disclosed how quickly an erection can be achieved following administration. Our understanding is that this version of Levitra will only be available in 10 mg doses.